BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30391351)

  • 41. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
    Schmid JA; Birbach A
    Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
    Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
    J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency.
    Dinh T; Oh J; Cameron DW; Lee SH; Cowan J
    PLoS One; 2019; 14(10):e0223861. PubMed ID: 31613907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.
    Renella R; Picard C; Neven B; Ouachée-Chardin M; Casanova JL; Le Deist F; Cavazzana-Calvo M; Blanche S; Fischer A
    Br J Haematol; 2006 Sep; 134(5):510-6. PubMed ID: 16848795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Features Before Hematopoietic Stem Cell Transplantation or Enzyme Replacement Therapy of Children With Combined Immunodeficiency.
    Méndez-Echevarría A; Del Rosal T; Pérez-Costa E; Rodríguez-Pena R; Zarauza A; Ferreira-Cerdán A; Bravo M; Mellado MJ; López-Granados E
    Pediatr Infect Dis J; 2016 Jul; 35(7):794-8. PubMed ID: 27078120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Heterozygous Gain-of-Function Variant in IKBKB Associated with Autoimmunity and Autoinflammation.
    Sacco K; Kuehn HS; Kawai T; Alsaati N; Smith L; Davila B; Bundy V; Kuhns DB; Dobbs K; Delmonte O; Notarangelo LD; Rosenzweig SD; Keller MD
    J Clin Immunol; 2023 Feb; 43(2):512-520. PubMed ID: 36378426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
    Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent human genetic errors of innate immunity leading to increased susceptibility to infection.
    Moens L; Meyts I
    Curr Opin Immunol; 2020 Feb; 62():79-90. PubMed ID: 31935567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
    Fish JD; Duerst RE; Gelfand EW; Orange JS; Bunin N
    Bone Marrow Transplant; 2009 Feb; 43(3):217-21. PubMed ID: 18794870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.
    Okano T; Imai K; Tsujita Y; Mitsuiki N; Yoshida K; Kamae C; Honma K; Mitsui-Sekinaka K; Sekinaka Y; Kato T; Hanabusa K; Endo E; Takashima T; Hiroki H; Yeh TW; Tanaka K; Nagahori M; Tsuge I; Bando Y; Iwasaki F; Shikama Y; Inoue M; Kimoto T; Moriguchi N; Yuza Y; Kaneko T; Suzuki K; Matsubara T; Maruo Y; Kunitsu T; Waragai T; Sano H; Hashimoto Y; Tasaki K; Suzuki O; Shirakawa T; Kato M; Uchiyama T; Ishimura M; Tauchi T; Yagasaki H; Jou ST; Yu HH; Kanegane H; Kracker S; Durandy A; Kojima D; Muramatsu H; Wada T; Inoue Y; Takada H; Kojima S; Ogawa S; Ohara O; Nonoyama S; Morio T
    J Allergy Clin Immunol; 2019 Jan; 143(1):266-275. PubMed ID: 29778502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study.
    Touzot F; Neven B; Dal-Cortivo L; Gabrion A; Moshous D; Cros G; Chomton M; Luby JM; Terniaux B; Magalon J; Picard C; Blanche S; Fischer A; Cavazzana M
    J Allergy Clin Immunol; 2015 May; 135(5):1303-9.e1-3. PubMed ID: 25282016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematopoietic Stem Cell Transplantation Beyond Severe Combined Immunodeficiency: Seeking a Cure for Primary Immunodeficiency.
    Mitchell R
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):776-785. PubMed ID: 30832892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency.
    Dupuis-Girod S; Cancrini C; Le Deist F; Palma P; Bodemer C; Puel A; Livadiotti S; Picard C; Bossuyt X; Rossi P; Fischer A; Casanova JL
    Pediatrics; 2006 Jul; 118(1):e205-11. PubMed ID: 16769798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.
    Toubert A; Glauzy S; Douay C; Clave E
    Tissue Antigens; 2012 Feb; 79(2):83-9. PubMed ID: 22220718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hematopoietic engraftment of XLA bone marrow CD34(+) cells in NOG/SCID mice.
    Moreau T; Bardin F; Barlogis V; Le Deist F; Chabannon C; Tonnelle C
    Cytotherapy; 2009; 11(2):198-205. PubMed ID: 19235603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
    Knutsen AP; Wall DA
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunity to microbes: lessons from primary immunodeficiencies.
    Carneiro-Sampaio M; Coutinho A
    Infect Immun; 2007 Apr; 75(4):1545-55. PubMed ID: 17283094
    [No Abstract]   [Full Text] [Related]  

  • 60. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.